These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23294313)

  • 1. Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles.
    Hruby VJ; Cai M
    Annu Rev Pharmacol Toxicol; 2013; 53():557-80. PubMed ID: 23294313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4).
    Oishi S; Fujii N
    Org Biomol Chem; 2012 Aug; 10(30):5720-31. PubMed ID: 22517031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists.
    Våbenø J; Haug BE; Rosenkilde MM
    Future Med Chem; 2015; 7(10):1261-83. PubMed ID: 26144264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidomimetic toolbox for drug discovery.
    Lenci E; Trabocchi A
    Chem Soc Rev; 2020 Jun; 49(11):3262-3277. PubMed ID: 32255135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyr
    Altman RA; Sharma KK; Rajewski LG; Toren PC; Baltezor MJ; Pal M; Karad SN
    ACS Chem Neurosci; 2018 Jul; 9(7):1735-1742. PubMed ID: 29648788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclopropane-Based Peptidomimetics Mimicking Wide-Ranging Secondary Structures of Peptides: Conformational Analysis and Their Use in Rational Ligand Optimization.
    Mizuno A; Kameda T; Kuwahara T; Endoh H; Ito Y; Yamada S; Hasegawa K; Yamano A; Watanabe M; Arisawa M; Shuto S
    Chemistry; 2017 Mar; 23(13):3159-3168. PubMed ID: 28000361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new class of peptidomimetics targeting the polo-box domain of Polo-like kinase 1.
    Ahn M; Han YH; Park JE; Kim S; Lee WC; Lee SJ; Gunasekaran P; Cheong C; Shin SY; Kim HY; Ryu EK; Murugan RN; Kim NH; Bang JK
    J Med Chem; 2015 Jan; 58(1):294-304. PubMed ID: 25347203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side Chain Cyclized Aromatic Amino Acids: Great Tools as Local Constraints in Peptide and Peptidomimetic Design.
    Van der Poorten O; Knuhtsen A; Sejer Pedersen D; Ballet S; Tourwé D
    J Med Chem; 2016 Dec; 59(24):10865-10890. PubMed ID: 27690430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads.
    Hruby VJ; Balse PM
    Curr Med Chem; 2000 Sep; 7(9):945-70. PubMed ID: 10911024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization.
    Gentilucci L; De Marco R; Cerisoli L
    Curr Pharm Des; 2010; 16(28):3185-203. PubMed ID: 20687878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of peptides and therapeutic success in cancer.
    Pernot M; Vanderesse R; Frochot C; Guillemin F; Barberi-Heyob M
    Expert Opin Drug Metab Toxicol; 2011 Jul; 7(7):793-802. PubMed ID: 21457110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational Preferences and Antiproliferative Activity of Peptidomimetics Containing Methyl 1'-Aminoferrocene-1-carboxylate and Turn-Forming Homo- and Heterochiral Pro-Ala Motifs.
    Kovačević M; Čakić Semenčić M; Radošević K; Molčanov K; Roca S; Šimunović L; Kodrin I; Barišić L
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approaches to the design of bioavailable melanotropins.
    Zhou Y; Cai M
    Expert Opin Drug Discov; 2017 Oct; 12(10):1023-1030. PubMed ID: 28699792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidomimetics Targeting Protein-Protein Interactions for Therapeutic Development.
    Zhang G; Andersen J; Gerona-Navarro G
    Protein Pept Lett; 2018; 25(12):1076-1089. PubMed ID: 30381055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering "Antimicrobial Peptides" and Other Peptides to Modulate Protein-Protein Interactions in Cancer.
    Rubin SJS; Qvit N
    Curr Top Med Chem; 2020; 20(32):2970-2983. PubMed ID: 33087030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Peptides to Peptidomimetics: A Strategy Based on the Structural Features of Cyclopropane.
    Mizuno A; Matsui K; Shuto S
    Chemistry; 2017 Oct; 23(58):14394-14409. PubMed ID: 28632330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic alpha-conotoxin peptidomimetic chimeras as potent GLP-1R agonists.
    Swedberg JE; Schroeder CI; Mitchell JM; Durek T; Fairlie DP; Edmonds DJ; Griffith DA; Ruggeri RB; Derksen DR; Loria PM; Liras S; Price DA; Craik DJ
    Eur J Med Chem; 2015 Oct; 103():175-84. PubMed ID: 26352676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides and peptidomimetics as inhibitors of protein-protein interactions involving β-sheet secondary structures.
    Laxio Arenas J; Kaffy J; Ongeri S
    Curr Opin Chem Biol; 2019 Oct; 52():157-167. PubMed ID: 31590141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational modulator design by exploitation of protein-protein complex structures.
    Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA
    Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ghrelin Receptor Ligands Reaching Clinical Trials: From Peptides to Peptidomimetics; from Agonists to Antagonists.
    Vodnik M; Štrukelj B; Lunder M
    Horm Metab Res; 2016 Jan; 48(1):1-15. PubMed ID: 26551992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.